Lithium-neuroleptic neurotoxicity is dose dependent
- PMID: 2884238
Lithium-neuroleptic neurotoxicity is dose dependent
Abstract
Lithium-neuroleptic combination treatment was studied retrospectively. Six of 22 manic patients who were administered the combination developed neurotoxicity. The dosage of neuroleptic administered, and not the serum lithium level or lithium dose, predicted which patients became neurotoxic.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources